Clinrol
Clinrol is an Australian AI-native health technology company that operates a clinical trial recruitment and engagement platform connecting patients, research sites, sponsors, and CROs through AI-powered pre-screening, scheduling, and analytics across three integrated products spanning 12+ countries.
- Company typePrivate
- Founded2021
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Clinrol does
Clinrol is an Australian health technology company headquartered in Sydney that operates an AI-native clinical trial recruitment and engagement platform, founded in 2021. The company connects patients, research sites, sponsors, and CROs through three integrated sub-brands: Clinrol Connect (an AI patient recruitment platform for research sites handling enquiries, voice calls, SMS, eligibility checks, appointments, and follow-ups), Clinrol Recruit (an end-to-end recruitment solution for sponsors and CROs managing acquisition, screening, medical review, and site-ready referrals), and Clinrol Engage (a patient-facing portal enabling trial discovery and AI-powered eligibility matching). Underlying these products is Ayla, an autonomous AI recruitment agent that conducts outbound voice calls, performs protocol-specific screening, captures structured responses, books appointments, and escalates complex cases to human staff.
The platform integrates with clinical trial management systems (RealTime, CRIO), CRM (Salesforce, HubSpot), communication (Twilio, Calendly, Microsoft Outlook), data management (REDCap, Veeva, Research Manager), marketing (Meta Ads, Google Ads), and cloud infrastructure (AWS), with ISO 27001, HIPAA, GDPR, and Australian Privacy Principles compliance built in. Clinrol supports more than 100 trials across 12 countries, has facilitated 200,000+ patient referrals, holds 300,000+ patients in its recruitment database, and covers 30+ therapeutic areas. Named customers and partners include Eli Lilly, Moderna, LEO Pharma, The University of Sydney, Paratus Clinical, Citeline, Canopy Clinical Research, and SubjectWell.
Clinrol generates revenue through a combination of SaaS subscriptions for Clinrol Connect and Clinrol Recruit, transparent ad-spend pass-through for patient acquisition campaigns, per-referral performance fees for site-ready candidate delivery, and outcome-aligned per-enrolment success fees tied to randomisation and study milestones. Go-to-market is primarily enterprise sales targeting sponsors, CROs, and research site networks through study scoping consultations, demo-first engagement via Calendly, and 30-day pilot programs, complemented by a self-serve patient trial-discovery portal. Geographic presence spans Australia, New Zealand, Singapore, Malaysia, Thailand, Taiwan, the US, Canada, the UK, and broader EMEA/LatAm markets under a claimed global footprint.
Clinrol firmographics
Firmographics- Name
- Clinrol
- Legal name
- Clinrol Pty Ltd
- Website
- https://clinrol.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Clinrol is an Australian AI-native health technology company that operates a clinical trial recruitment and engagement platform connecting patients, research sites, sponsors, and CROs through AI-powered pre-screening, scheduling, and analytics across three integrated products spanning 12+ countries.
- Ownership category
- akta.pro rank
Clinrol industry classification
Industry- Product category
- Clinical Trial Recruitment Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Patient App, Adherence & Engagement for RPM Programs (HLACAFAJ)
Keywords
Where Clinrol is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Clinrol business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain, Operations
Revenue model
- Subscription Platform Fees: SaaS platform subscription for Clinrol Connect (research sites) and Clinrol Recruit (sponsors/CROs) with full platform access during pilots and ongoing use.
- Ad Spend Pass-through: Transparent media spend for patient acquisition campaigns passed through to sponsors with no hidden mark-up on digital advertising.
- Per-Referral Fee: Performance-based fee charged when a verified, site-ready candidate is delivered to research sites.
- Per-Enrolment Success Fee: Outcome-aligned pricing tied to randomisation and study milestones, sharing recruitment risk with sponsors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | 30-day pilot with full platform access |
| Outcome Based/ Performance | Multi-year contract | Outcome-based pricing for sponsors/CROs |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Clinrol product offering
Product offeringCore offering
Clinrol is an AI-native clinical trial operating system that connects patient recruitment, engagement, and retention in one compliant platform. It comprises three integrated products: Clinrol Connect (for research sites to manage patient enquiries, AI calls, SMS, eligibility checks, appointments, and follow-ups), Clinrol Recruit (for sponsors and CROs to manage end-to-end patient acquisition and referral delivery), and Clinrol Engage (for patients to find and apply to trials). The platform is powered by Ayla, an autonomous AI agent that conducts voice outreach, protocol-specific pre-screening, scheduling, and escalates complex cases to humans.
Product overview
Clinrol is an AI-native clinical trial operating system comprising three integrated products: Clinrol Connect (for research sites to manage patient recruitment, AI pre-screening, and engagement), Clinrol Recruit (for sponsors and CROs to manage end-to-end patient acquisition and referral delivery), and Clinrol Engage (for patients to find and apply to trials). The platform is unified by an AI agent called Ayla that powers autonomous patient outreach and screening across all products, with real-time analytics and compliance controls (ISO 27001, HIPAA, GDPR, Australian Privacy Principles) built throughout.
Differentiator
Problem solved
Functional benefit
Brands
- Clinrol Connect: AI patient recruitment platform for clinical trial research sites - manages patient enquiries, AI calls, SMS, eligibility checks, appointments and follow-ups in one compliant platform
- Clinrol Recruit
- Clinrol Engage
Products and services
- Clinrol Connect AI-native patient recruitment and engagement platform for clinical trial research sites that manages patient enquiries, AI voice calls, SMS communications, eligibility checks, appointments, and follow-ups in one compliant platform with real-time recruitment analytics. Designed for independent sites, site networks, and academic medical centres to streamline recruitment, reduce coordinator workload, and accelerate enrolment.
- Clinrol Recruit End-to-end patient recruitment solution for pharmaceutical sponsors and Contract Research Organisations that manages acquisition, AI screening, human verification, medical review, and delivers site-ready patient referrals with real-time performance visibility across campaigns and sites across ANZ, APAC, and global markets.
- Clinrol Engage Patient-facing application and portal enabling patients to search and find suitable clinical trials using AI matching against live eligibility criteria in plain language, apply to trials, and manage communications with research sites.
Quantifiable outcome
- 70% reduction in routine pre-screening and follow-up time for site staff
- +4 more outcomes
Companies that use Clinrol
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
Clinrol technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration16 records
AI capability9 records
Feature8 records
Clinrol partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Canopy Clinical ResearchcoreCanopy Clinical Research adopted Clinrol as its preferred patient recruitment technology partner. Clinrol helps Canopy streamline outreach, reduce manual coordination, and create a more connected experience for patients across their clinical trial operations.
Scale indicators14 records
Recent moves6 records
Expansion highlights6 records
Clinrol competitors and assessment
Company assessmentEmerging players
- Trial Library: Trial discovery and matching platform for patients and referring providers. Comparable in patient-facing trial search and matching functionality similar to Clinrol Engage.
- Medable: Decentralized clinical trial platform enabling remote patient participation and engagement. Comparable in modernizing clinical trial workflows, with partial overlap in patient engagement and screening tooling.
- Deep 6 AI: AI-driven patient recruitment and clinical trial matching using EHR data mining. Comparable emerging player in applying AI to trial patient identification, addressing similar pain points as Clinrol Recruit.
- Mendel: AI platform for clinical trial feasibility, patient cohort discovery, and recruitment. Comparable emerging player with overlap in AI-based patient identification for pharma-sponsored trials.
- Curebase: Decentralized and hybrid clinical trial platform with site-based research services. Adjacent emerging player in digital clinical trial delivery with overlapping customer base of sponsors and CROs.
- Massive Bio: AI-enabled oncology clinical trial matching and recruitment. Overlap with Clinrol in AI-driven patient-trial matching for sponsor clients.
Broad incumbents
- IQVIA: Largest global CRO and clinical research services provider with extensive patient recruitment capabilities. Broad incumbent competing for the same sponsor budgets as Clinrol Recruit.
- Veeva Systems: Dominant CTMS and clinical operations platform serving global pharma. Broader incumbent that owns the workflow in which Clinrol operates and already integrates with; potential competitor if it expands into AI recruitment.
Direct peers
- Antidote: Clinical trial matching and patient recruitment platform using structured eligibility data to connect patients with trials. Closely aligned with Clinrol's Clinrol Engage product offering for patient discovery and matching.
- SubjectWell: Patient recruitment services and platform for clinical trials, connecting sponsors with potential participants. Direct comparable given Clinrol's similar recruitment focus and the fact that SubjectWell is also listed as a Clinrol customer/partner.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Clinrol social profiles
Digital presenceClinrol compliance and trust
Trust signalCompliance5 records
Clinrol financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clinrol leadership team
Management profileNumber of profiles
Clinrol funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clinrol M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clinrol
What does Clinrol do?
Clinrol is an AI-native clinical trial operating system that connects patient recruitment, engagement, and retention in one compliant platform. It comprises three integrated products: Clinrol Connect (for research sites to manage patient enquiries, AI calls, SMS, eligibility checks, appointments, and follow-ups), Clinrol Recruit (for sponsors and CROs to manage end-to-end patient acquisition and referral delivery), and Clinrol Engage (for patients to find and apply to trials). The platform is powered by Ayla, an autonomous AI agent that conducts voice outreach, protocol-specific pre-screening, scheduling, and escalates complex cases to humans.
Is Clinrol a public or private company?
Clinrol is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Clinrol founded?
Clinrol was founded in 2021. It employs 11 to 50 people.
Where is Clinrol based?
Clinrol is headquartered in Sydney, Australia, in the Oceania region.
How does Clinrol make money?
Four revenue lines are on record. Subscription Platform Fees are the primary driver. The others are ad Spend Pass-through, per-Referral Fee and per-Enrolment Success Fee.
Who are Clinrol's main competitors?
Emerging players on record are Trial Library, Medable, Deep 6 AI, Mendel, Curebase and Massive Bio. Broad incumbents are IQVIA and Veeva Systems. Direct peers are Antidote and SubjectWell.
Does Clinrol have an API?
No public API is recorded for Clinrol.
What industry is Clinrol in?
Clinrol's product category is Clinical Trial Recruitment Software. Its primary akta.pro industry code is HLACAFAJ, Patient App, Adherence & Engagement for RPM Programs. Its NAICS code is 513210 and its SIC code is 7372.